A detailed history of Relative Value Partners Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Relative Value Partners Group, LLC holds 1,690 shares of AMGN stock, worth $473,115. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,690
Previous 1,560 8.33%
Holding current value
$473,115
Previous $443,000 19.19%
% of portfolio
0.07%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$262.75 - $319.31 $34,157 - $41,510
130 Added 8.33%
1,690 $528,000
Q1 2024

May 13, 2024

BUY
$268.87 - $324.56 $268 - $324
1 Added 0.06%
1,560 $443,000
Q4 2023

Feb 12, 2024

BUY
$255.7 - $288.46 $511 - $576
2 Added 0.13%
1,559 $449,000
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $340,438 - $422,663
1,557 New
1,557 $418,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Relative Value Partners Group, LLC Portfolio

Follow Relative Value Partners Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Relative Value Partners Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Relative Value Partners Group, LLC with notifications on news.